Intertek partners with CrystecPharma to advance formulation science and accelerate development timelines for dry powder inhaler products
Cambridge, UK: Intertek, a leading Total Quality Assurance provider to industries worldwide, is pleased to announce that it has entered a partnership with CrystecPharma, focusing on advancing formulation science and accelerating development timelines for inhaled medicines, particularly dry powder inhaler (DPI) products.